Dr. Bruce Given notifies ICON that he will not seek a further term as Chairman of the Board
29 Novembro 2012 - 9:00AM
Business Wire
ICON plc. (NASDAQ:ICLR) (ISIN:IE0005711209), a
global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries, today
announced that Dr. Bruce Given, non-executive chairman of the
board, has notified the company that it is his intention not to
seek a second term as chairman when his current term expires on
December 31st 2012. Dr. Given has served as ICON’s chairman since
1st January 2010 and has been a member of the company’s board of
directors since 2004.
Dr. Given commented, “The time commitment for the chairman’s
role was increasingly challenging given my operational
responsibilities outside of ICON. Having overseen a very successful
transition in the executive leadership of the company, new
strategic alliances, as well as a return to strong growth in
revenues and earnings, I believe the timing is right for me to
relinquish the chair.”
On behalf of the board, Mr. Ciaran Murray, ICON CEO, commented,
“I would like to thank Bruce for his leadership and support over
the past three years in his role as chairman.”
The board of directors will now initiate a process to select a
new chairman, from among its members, to be appointed with effect
from January 1st 2013.
The information contained in this release is as of 29th November
2012. The statements made in this press release may contain
forward-looking statements that involve a number of risks and
uncertainties. A description of risks and uncertainties relating to
ICON and its business can be found in ICON’s Annual Report for the
fiscal year ended December 31, 2011 and in the forms filed with the
US Securities and Exchange Commission, including the Forms 20-F,
F-1, S-8 and F-3. ICON disclaims any intent or obligation to update
these forward-looking statements.
About ICON plc:
ICON plc is a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries.
The company specialises in the strategic development, management
and analysis of programs that support clinical development - from
compound selection to Phase I-IV clinical studies. With
headquarters in Dublin, Ireland, ICON currently, operates from 82
locations in 40 countries and has approximately 9,430 employees.
Further information is available at www.iconplc.com.
ICON/ICLR-F
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
